Measles Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Measles Epidemiology Forecast Report Coverage

Expert Market Research's “Measles Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of Measles. It projects the future incidence and prevalence rates of Measles cases across various populations. The study covers age, gender, and type as major determinants of the Measles population. The report highlights patterns in the prevalence of Measles overtime and projects future trends based on multiple variables.

Measles Understanding: Disease Overview

Measles remains a highly contagious acute viral respiratory disease caused by measles virus, an enveloped, negative-sense single-stranded RNA virus of the Morbillivirus genus. Transmission occurs predominantly through respiratory droplets and fine aerosol particles, and the virus can spread extraordinarily efficiently in populations with insufficient immunity. Infection typically causes fever, cough, coryza, conjunctivitis and a generalized maculopapular rash, but serious complications include pneumonia, encephalitis, severe diarrhea, dehydration, blindness and death.

Key Report Insights

Measles Epidemiology Perspective

The Measles epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the Measles epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for Measles and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Read more about this report - Request a Free Sample

Country-wise Measles Epidemiology

The Measles epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

According to contemporary 2023–2026 evidence, major gaps remain in measles epidemiology, vaccination coverage, surveillance and outbreak control. The central epidemiological problem is the accumulation of susceptible individuals after missed routine immunizations. WHO/CDC estimated 10.3 million infections in 2023 and approximately 11 million in 2024, despite measles being preventable through a highly effective vaccine. A major opportunity therefore exists in restoring routine two-dose vaccination coverage. In 2024, global first-dose coverage reached 84% and second-dose coverage 76%, leaving a substantial number of susceptible children. Reaching the approximately 95% two-dose population-immunity threshold is the principal long-term strategy for preventing sustained transmission.

Measles: Treatment Overview

The management of measles primarily focuses on prevention, rapid diagnosis, supportive treatment and interruption of transmission. There is currently no specific antiviral therapy approved by the U.S. FDA for treatment of measles, making vaccination and outbreak control the dominant components of disease management. Supportive care is the foundation of treatment for uncomplicated infection. Patients require adequate hydration, nutritional support, fever management and clinical monitoring for respiratory or neurological deterioration. Most uncomplicated cases recover without specific antiviral therapy. Pneumonia management requires early recognition of respiratory compromise and treatment of secondary bacterial infections when clinically indicated. Pneumonia remains one of the leading causes of severe measles morbidity and mortality, particularly among young children and malnourished patients.

Key Questions Answered

• What is the current and projected burden of Measles across the 8 major markets?
• Which countries across the 8 major markets account for the highest Measles patient populations and fastest growth rates?
• What is the diagnosed versus undiagnosed patient population of Measles across key countries in the 8 major markets?
• Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of Measles across the 8 major markets?
• What are the major drivers contributing to the increasing burden of Measles across the 8 major markets?
• How do major comorbidities and risk factors influence Measles epidemiology trends across the 8 major markets?
• What are the regional trends in advanced disease progression, treatment uptake, and patient management of Measles across the 8 major markets?
• Which patient segments represent the highest unmet clinical need in the Measles landscape across the 8 major markets?
• Which therapeutic areas linked to Measles are expected to witness the strongest growth opportunities across the 8 major markets?
• How is the Measles epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
• Which countries across the 8 major markets offer the most attractive market opportunities based on Measles epidemiology and healthcare infrastructure?
• Which epidemiological trends are expected to influence future drug development and market access strategies for Measles across the 8 major markets?

Scope of the Measles Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of Measles based on several factors.
• Measles Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The Measles report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Allergic Conjunctivitis Treatment Market

Vaccine Vials Market